In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains antibodies against the coronavirus.
While the vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are administered, and extensive research is conducted for targeted therapeutics to control the COVID-19 ...
Tiny llama nanobodies neutralize different noroviruses: Can they improve human anti-viral therapies?
Researchers investigated a novel strategy to neutralize human noroviruses. They tested the ability of tiny antibodies produced by llamas, called nanobodies, to effectively neutralize human norovirus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback